MedTrace Logo

Ticagrelor in Fuwai Hospital

NCT02765711 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2016-08-02

No results posted yet for this study

Summary

This is a single-arm non-interventional cohort study. This study is to describe the contemporary use of ticagrelor in a "real-world" setting, to reflect its acceptance and patients' compliance, and to observe its one-year safety in patients with acute coronary syndrome in Fuwai Hospital.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    lead OTHER

Principal Investigators

  • Hongbing Yan, MD · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02765711 on ClinicalTrials.gov